What is cholangiocarcinoma? See here

Cholangiocarcinoma occurs in the intrahepatic and extrahepatic bile ducts, including malignant tumors from the hilar area to the lower part of the common bile duct. It is mainly a type of liver cancer. Unlike hepatocellular cancer, the treatment effect is not very good. The specific survival time of patients varies greatly in various aspects. Patients with longer survival time have well-differentiated bile duct cancer. The incidence rate is not high, and surgical resection is the main treatment. The surgical resection rate is not high. Tumor cell cancer can be treated with ablation therapy and arterial infusion chemotherapy.

Cancer is a big clinical problem. Some patients are almost incurable if they are in the late stage, so it is a fatal disease. Cholangiocarcinoma is one of them. It is very scary for patients and their lives are likely to be threatened. It must be diagnosed by a professional doctor before treatment. Many people don’t know what is going on. What is cholangiocarcinoma?
What is cholangiocarcinoma ? Cholangiocarcinoma refers to a malignant tumor originating from the intrahepatic and extrahepatic bile ducts, including the hilar area to the lower end of the common bile duct. Cholangiocarcinoma is highly malignant, and its incidence has been increasing year by year in recent years. Cholangiocarcinoma is a type of liver cancer in the traditional cancer classification, but in fact it is different from hepatocellular cancer. Cholangiocarcinoma is a cancer originating from the epithelial cells of the liver bile duct system. Traditional treatment is not effective, and it is not discovered in time. Jaundice usually occurs, and after examination, it is found to be cholangiocarcinoma.
How long can you live with cholangiocarcinoma? <br/>The survival time of patients with cholangiocarcinoma varies greatly in various aspects. Some patients can survive up to 20 years. These patients with longer survival time belong to well-differentiated cholangiocarcinoma. On the contrary, patients with poorly differentiated cholangiocarcinoma have a higher degree of malignancy and a limited survival time. In addition, the patient's survival time is related to the comprehensive treatment after surgery. Patients need comprehensive radiotherapy and chemotherapy to prolong their lives.
Treatment of cholangiocarcinoma <br/>Currently, there is no specific research to prove that cholangiocarcinoma is caused by a certain reason. There are reports that it may be related to gallstones, but the incidence of gallstones in China is very high, but the incidence of cholangiocarcinoma is not high. The first choice for cholangiocarcinoma is surgical resection, because it is already in the late stage when it is discovered, so the surgical resection rate is not high. Cholangiocarcinoma is not sensitive to radiotherapy and chemotherapy, and chemotherapy and radiotherapy are not recommended. Minimally invasive tumors can be used for tumor cell carcinoma. Ablation therapy and arterial infusion chemotherapy can be performed.
Cholangiocarcinoma mainly occurs in the intrahepatic and extrahepatic bile ducts, that is, malignant tumors from the liver hilar area to the lower end of the common bile duct. It is highly malignant and the incidence rate is increasing year by year. The patient's survival is related to many factors, including the specific time and postoperative comprehensive treatment. Patients need comprehensive radiotherapy and chemotherapy to prolong their lives, and they mainly need to cooperate with the treatment.